These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8384359)
1. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Storey A; Banks L Oncogene; 1993 Apr; 8(4):919-24. PubMed ID: 8384359 [TBL] [Abstract][Full Text] [Related]
2. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
3. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Demers GW; Halbert CL; Galloway DA Virology; 1994 Jan; 198(1):169-74. PubMed ID: 8259651 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
6. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells. Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030 [TBL] [Abstract][Full Text] [Related]
7. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Liu Z; Ghai J; Ostrow RS; Faras AJ Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro. Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Hiraiwa A; Kiyono T; Segawa K; Utsumi KR; Ohashi M; Ishibashi M Virology; 1993 Jan; 192(1):102-11. PubMed ID: 8390746 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activation by the E6 gene product of human papillomavirus type 16. Klingelhutz AJ; Foster SA; McDougall JK Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Pim D; Storey A; Thomas M; Massimi P; Banks L Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of transformation by the human papillomaviruses. Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182 [TBL] [Abstract][Full Text] [Related]
13. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
14. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells. Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Thomas M; Matlashewski G; Pim D; Banks L Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365 [TBL] [Abstract][Full Text] [Related]
16. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
17. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. Liu Z; Ghai J; Ostrow RS; McGlennen RC; Faras AJ Virology; 1994 Jun; 201(2):388-96. PubMed ID: 8184549 [TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
19. Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53. Storey A; Massimi P; Dawson K; Banks L Oncogene; 1995 Aug; 11(4):653-61. PubMed ID: 7651728 [TBL] [Abstract][Full Text] [Related]
20. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. Banks L; Moreau F; Vousden K; Pim D; Matlashewski G J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]